Both in Biotechnology
Aura Biosciences vs Candel Therapeutics
Over the past year AURA returned −0.2% and CADL returned +55.6%; their daily moves had a correlation of 0.39.
AURA −0.2% CADL +55.6%Growth of $1, one year, split-adjusted
| Metric | AURA | CADL |
|---|---|---|
| Price | $6.03 | $8.12 |
| Market cap | $625.3M | $621.3M |
| Today | −1.79% | −2.52% |
| 1 month | −1.0% | −20.2% |
| 6 months | −27.8% | +7.8% |
| Year to date | +10.6% | +43.7% |
| 1 year | −0.8% | +45.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $323.8M | $153.7M |
| Dividend yield | — | — |
| Volatility (60d) | 41.0% | 65.2% |
| Short % of float | 11.8% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).